X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (177) 177
humans (176) 176
male (120) 120
female (119) 119
child (106) 106
clinical neurology (93) 93
child, preschool (91) 91
adolescent (81) 81
oncology (80) 80
infant (76) 76
medulloblastoma (72) 72
adult (67) 67
supratentorial neoplasms - pathology (66) 66
pediatrics (56) 56
supratentorial (56) 56
neuroectodermal tumors, primitive - pathology (55) 55
children (54) 54
brain tumors (52) 52
central-nervous-system (51) 51
chemotherapy (48) 48
magnetic resonance imaging (47) 47
surgery (43) 43
brain-tumors (38) 38
combined modality therapy (38) 38
medicine & public health (38) 38
retrospective studies (37) 37
neurosciences (36) 36
prognosis (36) 36
supratentorial neoplasms - surgery (36) 36
tumors (34) 34
cancer (33) 33
primitive neuroectodermal tumor (33) 33
radiotherapy (33) 33
brain neoplasms - pathology (32) 32
childhood (32) 32
pathology (32) 32
primitive neuroectodermal tumors (31) 31
neuroectodermal tumors, primitive - genetics (30) 30
supratentorial neoplasms - genetics (29) 29
pnet (28) 28
supratentorial neoplasms - therapy (28) 28
brain (27) 27
middle aged (27) 27
neuroectodermal tumors, primitive - therapy (27) 27
radiation (27) 27
supratentorial primitive neuroectodermal tumor (27) 27
treatment outcome (26) 26
childrens cancer group (24) 24
immunohistochemistry (24) 24
supratentorial neoplasms - diagnosis (24) 24
prognostic-factors (23) 23
antineoplastic combined chemotherapy protocols - therapeutic use (22) 22
supratentorial neoplasms - drug therapy (22) 22
comparative genomic hybridization (21) 21
survival rate (21) 21
young adult (21) 21
infant, newborn (20) 20
neuroectodermal tumors, primitive - surgery (20) 20
neurology (20) 20
supratentorial neoplasms - radiotherapy (20) 20
brain neoplasms - genetics (19) 19
prognostic factors (19) 19
radiology, nuclear medicine & medical imaging (19) 19
survival (19) 19
diagnosis, differential (18) 18
follow-up studies (18) 18
neurosurgery (18) 18
expression (17) 17
gliomas (17) 17
neuroectodermal tumors, primitive - drug therapy (17) 17
medulloblastoma - genetics (16) 16
neuroectodermal tumors, primitive - radiotherapy (16) 16
pineoblastoma (16) 16
brain neoplasms - therapy (15) 15
diagnosis (15) 15
brain tumor (14) 14
care and treatment (14) 14
cerebellar neoplasms - pathology (14) 14
disease-free survival (14) 14
ependymoma (14) 14
hematology (14) 14
infancy (14) 14
medulloblastoma - pathology (14) 14
supratentorial pnet (14) 14
aged (13) 13
brain neoplasms - surgery (13) 13
neuroectodermal tumors, primitive - diagnosis (13) 13
research (13) 13
supratentorial neoplasms - mortality (13) 13
brain neoplasms - diagnosis (12) 12
cranial irradiation (12) 12
differentiation (12) 12
high-dose chemotherapy (12) 12
neuroectodermal tumors, primitive - metabolism (12) 12
neuroectodermal tumors, primitive - mortality (12) 12
neuroimaging (12) 12
supratentorial neoplasms - diagnostic imaging (12) 12
adjuvant chemotherapy (11) 11
brain neoplasms - mortality (11) 11
cerebellar neoplasms - genetics (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Acta Oncologica, ISSN 0284-186X, 06/2017, Volume 56, Issue 5, pp. 698 - 705
Journal Article
Neuro-Oncology, ISSN 1522-8517, 02/2009, Volume 11, Issue 1, pp. 33 - 40
We undertook this study to estimate the event-free survival (EFS) of patients with newly diagnosed supratentorial primitive neuroectodermal tumor (SPNET)... 
Autologous stem cell rescue | Craniospinal radiotherapy | Dose-intensive chemotherapy | Supratentorial PNET | Event-free survival | Risk-adapted therapy | STEM-CELL RESCUE | risk-adapted therapy | event-free survival | CRANIOSPINAL RADIATION-THERAPY | autologous stem cell rescue | MALIGNANT BRAIN-TUMORS | CLINICAL NEUROLOGY | PRIMITIVE NEUROECTODERMAL TUMORS | NEWLY-DIAGNOSED MEDULLOBLASTOMA | supratentorial PNET | craniospinal radiotherapy | dose-intensive chemotherapy | REQUIRING PROLONGED OBSERVATION | ONCOLOGY | CENTRAL-NERVOUS-SYSTEM | HIGH-DOSE CHEMOTHERAPY | CHILDRENS CANCER GROUP | COMPARATIVE GENOMIC HYBRIDIZATION | Gamma Rays | Cyclophosphamide - administration & dosage | Neuroectodermal Tumors, Primitive - drug therapy | Humans | Brain Neoplasms - pathology | Child, Preschool | Male | Cisplatin - administration & dosage | Supratentorial Neoplasms - drug therapy | Supratentorial Neoplasms - therapy | Vincristine - administration & dosage | Female | Brain Neoplasms - radiotherapy | Child | Supratentorial Neoplasms - pathology | Risk Factors | Hematopoietic Stem Cell Transplantation | Survival Rate | Treatment Outcome | Combined Modality Therapy | Neuroectodermal Tumors, Primitive - therapy | Brain Neoplasms - drug therapy | Cranial Irradiation | Supratentorial Neoplasms - radiotherapy | Disease-Free Survival | Pilot Projects | Neuroectodermal Tumors, Primitive - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Brain Neoplasms - therapy | Dose-Response Relationship, Radiation | Neuroectodermal Tumors, Primitive - pathology | Index Medicus | Clinical Investigations
Journal Article
Journal Article
The Indian Journal of Pediatrics, ISSN 0019-5456, 5/2011, Volume 78, Issue 5, pp. 613 - 615
Primitive Neuroectodermal tumours (PNET) are small-cell malignant embryonal tumors showing divergent differentiation of variable degree into neuronal, glial,... 
Pediatrics | Medicine & Public Health | Gynecology | Medulloblastoma | Ependymoblastoma | PNET | Supratentorial tumour | Cerebral neuroblastoma | PRIMITIVE NEUROECTODERMAL TUMORS | PEDIATRICS | RADIOTHERAPY | Infant | Male | Supratentorial Neoplasms - diagnosis | Humans | Neuroectodermal Tumors, Primitive - diagnosis | Fatal Outcome | Gliomas | Brain tumors | Stem cells | Index Medicus
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2006, Volume 64, Issue 4, pp. 1031 - 1037
Supratentorial primitive neuroectodermal tumors (S-PNET) are rare and have a grim prognosis, frequently taking an aggressive course with local relapse and... 
Childhood brain tumors | HART | S-PNET | High-dose chemotherapy | SURVIVAL | STEM-CELL RESCUE | PROGNOSTIC-FACTORS | HIGH-RISK MEDULLOBLASTOMA | childhood brain tumors | CANCER GROUP | RADIATION | POSTOPERATIVE CHEMOTHERAPY | ONCOLOGY | PINEALOBLASTOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | BRAIN | high-dose chemotherapy | Cyclophosphamide - administration & dosage | Prospective Studies | Thiotepa - administration & dosage | Neuroectodermal Tumors, Primitive - drug therapy | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Male | Supratentorial Neoplasms - drug therapy | Vincristine - administration & dosage | Dose Fractionation | Female | Chemotherapy, Adjuvant | Child | Carboplatin - administration & dosage | Etoposide - administration & dosage | Treatment Outcome | Chi-Square Distribution | Supratentorial Neoplasms - radiotherapy | Stem Cell Transplantation - methods | Neuroectodermal Tumors, Primitive - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Survival Analysis | Methotrexate - administration & dosage | Lomustine - administration & dosage | Chemotherapy | Cyclophosphamide | Brain tumors | Lomustine | Etoposide | Development and progression | Metastasis | Methotrexate | Radiotherapy | Antitank weapons | Cancer | Index Medicus
Journal Article
Pediatric Blood and Cancer, ISSN 1545-5009, 03/2008, Volume 50, Issue 3, pp. 554 - 560
Purpose. To evaluate the efficacy and toxicity of hypofractionated stereotactic radiotherapy in the management of locally recurrent or residual central nervous... 
PNET | Stereotactic radiotherapy (SCRT) | Residual disease | Recurrent medulloblastoma | ADJUVANT CHEMOTHERAPY | STEM-CELL RESCUE | CRANIOSPINAL RADIATION-THERAPY | PROGNOSTIC-FACTORS | residual disease | stereotactic radiotherapy (SCRT) | PRIMITIVE NEUROECTODERMAL TUMORS | ADULT MEDULLOBLASTOMA | ONCOLOGY | PEDIATRIC BRAIN-TUMORS | CONFORMAL RADIOTHERAPY | SKULL BASE TUMORS | PEDIATRICS | HIGH-DOSE CHEMOTHERAPY | recurrent medulloblastoma | HEMATOLOGY | Neoplasm Recurrence, Local - radiotherapy | Neuroectodermal Tumors, Primitive - drug therapy | Humans | Child, Preschool | Male | Palliative Care | Supratentorial Neoplasms - drug therapy | Neoplasm, Residual | Medulloblastoma - radiotherapy | Medulloblastoma - pathology | Adult | Dose Fractionation | Female | Medulloblastoma - surgery | Retrospective Studies | Cerebellar Neoplasms - pathology | Child | Cerebellar Neoplasms - drug therapy | Supratentorial Neoplasms - pathology | Combined Modality Therapy | Neuroectodermal Tumors, Primitive - surgery | Supratentorial Neoplasms - surgery | Stereotaxic Techniques | Supratentorial Neoplasms - radiotherapy | Neuroectodermal Tumors, Primitive - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Cerebellar Neoplasms - surgery | Medulloblastoma - drug therapy | Cerebellar Neoplasms - radiotherapy | Neuroectodermal Tumors, Primitive - pathology | Radiotherapy, Conformal - methods | Index Medicus
Journal Article
Radiotherapy and Oncology, ISSN 0167-8140, 2009, Volume 92, Issue 1, pp. 83 - 88
Journal Article
Journal Article
Pediatric Blood and Cancer, ISSN 1545-5009, 04/2007, Volume 48, Issue 4, pp. 416 - 422
Journal Article
19.